{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "55154-5783",
      "generic_name": "GUAIFENESIN and DEXTROMETHORPHAN",
      "labeler_name": "Cardinal Health 107, LLC",
      "brand_name": "GUAIFENESIN DM",
      "active_ingredients": [
        {
          "name": "GUAIFENESIN",
          "strength": "100 mg/5mL"
        },
        {
          "name": "DEXTROMETHORPHAN",
          "strength": "10 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "55154-5783-5",
          "description": "5 CUP, UNIT-DOSE in 1 BAG (55154-5783-5)  / 10 mL in 1 CUP, UNIT-DOSE",
          "marketing_start_date": "19920701",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Cardinal Health 107, LLC"
        ],
        "rxcui": [
          "996520"
        ],
        "spl_set_id": [
          "c5fd53c9-81d6-4ce6-88a0-c2c24e17a7ed"
        ],
        "upc": [
          "0055154578356"
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560",
          "N0000181821",
          "N0000182149",
          "N0000181819",
          "N0000182147"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]",
          "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
          "Sigma-1 Agonist [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "pharm_class_moa": [
          "Uncompetitive NMDA Receptor Antagonists [MoA]",
          "Sigma-1 Receptor Agonists [MoA]"
        ],
        "unii": [
          "495W7451VQ",
          "7355X3ROTS"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SYRUP",
      "spl_id": "488e60a0-83b2-47ca-8443-c29ff3bb63a3",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "19920701",
      "product_id": "55154-5783_488e60a0-83b2-47ca-8443-c29ff3bb63a3",
      "application_number": "M012",
      "brand_name_base": "GUAIFENESIN DM",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}